Evaluation of plasma and urinary salbutamol levels in COPD


Objective: To evaluate the use of trough plasma salbutamol and overnight urinary salbutamol excretion in the assessment of nebulised salbutamol delivery in patients with chronic obstructive pulmonary disease (COPD). Methods: Twenty in-patients with COPD receiving nebulised salbutamol, age 69.7 years, FEV1 38.1% predicted, were studied on two consecutive… (More)
DOI: 10.1007/s002280050166


1 Figure or Table

Cite this paper

@article{Clark1996EvaluationOP, title={Evaluation of plasma and urinary salbutamol levels in COPD}, author={D. Joseph Clark and K. S. Tan and Brian J Lipworth}, journal={European Journal of Clinical Pharmacology}, year={1996}, volume={51}, pages={91-93} }